Schoeneck James A - Insider Non-Derivative Transactions at Calidi Biotherapeutics, Inc. (CLDI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 28, 2024, Schoeneck James A's relationship to Calidi Biotherapeutics, Inc. (CLDI) is Director, and currently has 1,071,781 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CLDI insiders.
Data Source: SEC.
Schoeneck James A - Insider Non-Derivative Transactions of CLDI Common Stock
Schoeneck James A - Insider Non-Derivative Transactions at CLDI
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 29, 2024 | Acquisition -- (Common Stock) | 79687 | 0 | 1071781 |
| Jun 4, 2024 | M -- (Common Stock) | 173000 | 0.2 | 588887 |
| Jun 4, 2024 | M -- (Common Stock) | 375000 | 0.2 | 963887 |
| Apr 19, 2024 | Acquisition -- (Common Stock) | 375000 | 0.4 | 415887 |
| Mar 30, 2024 | Acquisition -- (Common Stock) | 28207 | 0 | 992094 |
| Dec 22, 2023 | Acquisition -- (Common Stock) | 10625 | 1.8 | 27872 |